Wells Fargo today maintained a Market Perform rating on Alexion Pharmaceuticals (NASDAQ: ALXN). This morning Alexion reported Q1 results.

This article: 112 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE